Counting Offit’s Millions: More on How Merck’s Rotateq Vaccine Made Paul Offit Wealthy
December 09, 2009
Counting Offit’s Millions: More on How Merck’s Rotateq Vaccine Made Paul Offit Wealthy
By Dan Olmsted and Mark Blaxill
Paul Offit, vaccine entrepreneur and public health spokesperson, has earned approximately $10 million in income from Rotateq® royalties through 2009 and stands to earn a total of between $13-35 million over the life of his rotavirus vaccine patents, according to a new analysis by Age of Autism
Labels: Counting Offit’s Millions: More on How Merck’s Rotateq Vaccine Made Paul Offit Wealthy
posted by concerned heart @ 6:55 AM
Stumble It!
http://www.stumbleupon.com/submit?url=http://www.yoursite.com/article.php&title=The+Article+Title
1 Comments:
The following is a correction to "Counting Offit's Millions", particularly regarding unacknowledged use of works by me (David Brown):
1. Offit's "disclosure" was made to me, in response to a question about only the CHOP share. (To the best of my recollection, I already was aware of his connections to Wistar at the time.) It was not "partial" with regards to the question.
2. It is probable that Offit is receiving continuing royalties for Rotateq from Wistar. However, by the figures Olmstead has given, the combined income for 2007-2009 should be ca. $1M, not $1.6M as seems to be assumed. Also, the best reason to suppose Offit has been paid, that he held a position at Wistar around the time the patent was filed, has not been acknowledged.
3. That the CHOP share was distributed by an agreement between the inventors, rather than direct application of policy, is a possibility I initially considered, but rejected and retracted as of ca. August 18.
4. Offit's disclosure, and other information relevant to the CHOP sale, was made available to AoA in August, which is far from "recent".
Post a Comment
<< Home